Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - SAfety & EffectiveneSS of Drug-ElUting Stents & Anti-platelet REgimen
Conditions
Interventions
- DEVICE: Everolimus-eluting coronary stenting system (EECSS, Promus Element)
- DEVICE: Zotarolimus-eluting coronary stenting system (ZECSS, Endeavor Resolute)
- DRUG: Triple anti-platelet therapy (TAT)
- DRUG: Double-dose clopidogrel anti-platelet therapy (DDAT)
Sponsor
Seoul National University Hospital
Collaborators